News

March 28, 2017

Antiva Biosciences Closes $22 Million Series C Financing Read more

August 6, 2015

Antiva Biosciences Raises $16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections Read more

August 6, 2015

With $16M Series B, Antiva Hopes to Kill Cancer-Causing HPV Read article (Xconomy)

August 6, 2015

Why a longtime biotech exec shunned retirement for a 'breakthrough' Read article (SF Business Journal)